Lowest Price Guaranteed From USD 3,499
Published
April 2018
Pages
200
View Count
5826
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
From my point of view, the prospects of spray drying for pharmaceutical products are promising. I believe that this technology may turn out to be a well-suited option for value added generics (or super generics); further, depending on the evolution of the aforementioned products, the growth may be impacted
-Director, Business Development, Spain based small-sized CMO
The origins of spray drying can be traced back to 1872, when the first patent related to the technique was registered in the US. The first commercial use of this form of drying was reported in the 1920s when powdered milk was introduced into the market. Spray drying, which is already established in the food and chemical sector, is also considered to be a rapid, cost-effective, and scalable process for the production of dry powder formulations of pharmacological material. Owing to characteristics, such as reproducibility and its continuous mode of operation, the technique has become very popular in the pharmaceutical and biotechnology industry. It offers several advantages over alternate drying technologies, such as lyophilization (characterized by high dependence on cold chain for storage and logistics, which is prone to failure due to human error) and vacuum foam drying (characterized by volumetric restrictions due to the properties of foam, which limits the quantity of sample that can be dried in a single run) that are currently deployed in the pharmaceutical industry.
Amongst other merits, spray drying is known to be suitable for drying heat-sensitive products such as biologics. Moreover, this method imparts improved properties to the formulations that can be administered through more efficient and less invasive modes of delivery, such as oral, and inhalation routes. The technology also aids in improving the compression properties of drugs, allowing developers to design concentrated dose variants of medications and reduce tablet size. Such alterations have the potential to improve patient compliance. Given the flexibility offered in terms of drug development and formulation, the economics of the technique, the introduction of aseptic methods, and the recent approval of the first spray dried biologic, Raplixa ®, the adoption of spray drying is anticipated to increase steadily in the pharmaceutical industry.
The ‘Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028’ report provides an extensive study on the use of spray drying in the pharmaceutical sector. The key focus of the report is primarily to estimate the future potential of spray drying in the manufacturing of APIs, inhalables, injectables, biologics and other pharmaceutical products. The study presents an in-depth analysis of a diverse set of companies that provide spray drying equipment and services across different regions of the globe.Amongst other elements, the report includes:
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on parameters, such as trends in the pharmaceutical contract manufacturing industry, operation costs associated with spray drying and the challenges and opportunities presented by this technique, we have provided an informed estimate of the likely evolution of the market in the long term, for the period 2018-2028. In addition, we have provided insights on the likely regional evolution of the market in North America, Europe, Asia Pacific and the rest of the world. It also includes estimates regarding the likely distribution of the market based on type of industry (pharmaceuticals and biologics) and type of nozzles used in spray dryers (fluid nozzle, pressure nozzle, rotary disc atomizer, centrifugal nozzle, and others). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have presented three different forecast scenarios, depicting conservative, base and optimistic tracks of the market’s evolution.
The research, analysis and insights presented in this report is backed by a deep understanding of insights gathered both from secondary and primary sources. The opinions and insights presented in this study were influenced by discussions conducted with several key players in this domain. The report features detailed transcripts of interviews held with the following key opinion leaders:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
Chapter 2 provides an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the spray drying market in the long term.
Chapter 3 provides an introduction to the spray drying approach, including a detailed discussion on the principle / process of spray drying, highlighting the key steps associated with the process. It highlights the important applications of the technique and the various features that distinguish it from alternative drying technologies. The chapter also features a discussion on the various advantages and limitations associated with spray drying.
Chapter 4 provides an overview of the applications of spray drying in the pharmaceutical industry, from generation of extremely fine particles for pulmonary administration to large agglomerated powders for oral formulations. Specifically, the different applications discussed in the chapter include enhancement of solubility and bioavailability, formulation of inhalables, taste masking, development of controlled release formulations, and aseptic production of biopharmaceuticals.
Chapter 5 includes a comprehensive market overview, featuring information on various types of spray dryers used in the pharmaceutical industry. It provides information on their respective manufacturers (company size and year of establishment) and presents an analyses of spray dryers on the basis of inlet temperature, type of nozzle (fluid, pressure, rotary disc and others) used, size of the unit (lab, clinical and commercial), and atomizing gas (air, nitrogen and inert gases) used. Further, the chapter includes a discussion on companies that offer pharmaceutical spray drying services. It presents an analysis of various spray drying service providers on the basis of the geographical location of their facilities, scale of operation (lab, clinical and commercial) and information on cGMP statuses of their facilities.
Chapter 6 presents the key insights derived from the study. It features detailed 2X2 matrices, comparing the spray drying capabilities and the supplier power of different spray drying service providers. A similar analysis comparing the spray dryer portfolio and the establishment year of different manufacturers of spray dryers, is also included in the chapter. In addition, the chapter features a comprehensive geographical landscape analysis, which highlights the spray drying activity across the globe, in terms of presence of both manufacturers and service providers.
Chapter 7 features tabular profiles of the most active service providers ( as identified in chapter 6 ) in the pharmaceutical industry. It highlights the expertise of these players in terms of their spray drying capabilities. Each profile provides a brief overview of the company, highlighting its employee strength ( if available ), its product / service portfolio, spray dryers used ( if available ) and the key developments related to spray drying ( if available ).
Chapter 8 provides detailed profiles of the most active spray dryer manufacturers ( as identified in chapter 6 ) in the pharmaceutical industry. Each profile provides a brief overview of the company, its financial information ( if available ), its portfolio of spray dryers, recent developments, and a comprehensive future outlook.
Chapter 9 features a case study on lyophilization of biologics, the key competing technique to spray drying. The chapter elaborates on the steps involved in lyophilization, and lyophilization cycle development and optimization. It includes an exemplary list of service providers offering lyophilization services with information on location of facilities, type of drug candidates lyophilized, scale of operation and the containment systems utilized for such operations.
Chapter 10 presents a detailed analysis of the mergers and acquisitions that have taken place within this industry. The chapter highlights the information on the acquiring and the acquired company (headquarters and the ownership (public / private)), along with the year of acquisition, acquiring amount ( if available ), and the financial status of the acquired company, at the time of acquisition. It features a detailed ownership change matrix depicting the distribution of mergers and acquisitions across private firms, public firms and sole proprietorships. It also includes an evaluation of the financials of these deals (revenues of the acquired firms at the time of acquisition and their respective deal multiples).
Chapter 11 presents a comprehensive market forecast analysis, highlighting the future potential of the spray drying services market till the year 2028. The chapter also presents detailed market segmentation on the basis of geographical regions (North America, Europe, Asia Pacific and the rest of the world), type of industry (pharmaceuticals and biologics), and type of nozzles used in spray dryers (fluid nozzle, pressure nozzle, rotary disc atomizer, centrifugal nozzle and others).
Chapter 12 presents a detailed analysis capturing the key parameters and trends that are likely to influence the future of the spray drying market, under a comprehensive SWOT framework. The chapter also features a schematic Harvey ball analysis to highlight the relative impact of each SWOT parameter on the overall market.
Chapter 13 is a summary of the overall report. In this chapter, we have provided a list of the key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.
Chapter 14 is a collection of transcripts of interviews held with key stakeholders in this market. In this chapter, we have presented the details of our conversations with Sam de Costa (Stabilisation Projects Manager, Nova Laboratories), Manuel Leal (Business Development Director, Idifarma), Anonymous (Founder, India based Manufacturer).
Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.
Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. The Spray Drying Process
3.1.1. Feed Preparation
3.1.2. Atomization
3.1.3. Feed Drying
3.1.4. Separation of the Powder, Cooling and Packaging
3.2. Applications of Spray Drying
3.3. Spray Drying of Biopharmaceuticals
3.4. Alternatives to Spray Drying
3.4.1. Lyophilization
3.4.2. Spray Freeze Drying
3.4.3. Atmospheric Spray Freeze Drying
3.4.4. Vacuum Foam Drying
3.5. Advantages and Limitations of Spray Drying
4. SPRAY DRYING: KEY APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
4.1. Chapter Overview
4.2. Enhancement of Solubility and Bioavailability
4.3. Distribution of Particle Size of Inhalable Drugs
4.4. Modified Release and Taste Masking
4.5. Aseptic Production of Pharmaceuticals
5. PHARMACEUTICAL SPRAY DRYING: MARKET OVERVIEW
5.1. Chapter Overview
5.2. Pharmaceutical Spray Dryers: List of Manufacturers
5.2.1. Distribution by Type of Nozzles
5.2.2. Distribution by Inlet Temperature
5.2.3. Distribution by Atomizing Gas
5.2.4. Key Manufacturers
5.3. Pharmaceutical Spray Drying: Service Providers
5.3.1. Distribution by Scale of Operation
5.3.2. Distribution by cGMP Availability
6.3.3. Popularly Used Spray Dryers
5.4. Pharmaceutical Spray Drying: Companies with In-house Facilities
5.5. Pharmaceutical Spray Drying: Companies Involved in Bioavailability Enhancement
6. SPRAY DRYING SERVICE AND EQUIPMENT PROVIDERS: COMPETITIVE LANDSCAPE
6.1. Chapter Overview
6.2. Pharmaceutical Spray Drying Service Providers: Competitive Landscape
6.3. Pharmaceutical Spray Dryer Manufacturers: Competitive Landscape
6.4. Pharmaceutical Spray Drying: Geographical Landscape
7. SPRAY DRYING SERVICE PROVIDERS: COMPANY PROFILES
7.1. Chapter Overview
7.2 Ajinomoto (Omnichem)
7.3. Almac Group
7.4. Biotech Investment Group (Formex)
7.5. Catalent Pharma Solutions
7.6. Coriolis Pharma
7.7. Evotec
7.8. Fuji Chemical Industry
7.9. Hovione
7.10. Idifarma
7.11. Lonza (Capsugel / Bend Research)
7.12.Micro-Sphere
7.13. Nova Laboratories
7.14. Patheon (Agere Pharmaceuticals)
7.15. Pulse Combustion Systems
7.16. Richman Chemical
7.17. Siegfried
7.18. Upperton
8. SPRAY DRYER MANUFACTURERS: COMPANY PROFILES
8.1. Chapter Overview
8.2. Buchi Labortechnik
8.2.1. Company Overview
8.2.2. Financial Overview
8.2.3. Portfolio of Spray Dryers and Services
8.2.4 Recent Developments
8.2.5 Future Outlook
8.3. GEA Niro
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Portfolio of Spray Dryers and Services
8.3.4. Recent Developments
8.3.5. Future Outlook
8.4. Hemraj India
8.4.1. Company Overview
8.4.2. Portfolio of Spray Dryers
8.4.3 Recent Developments
8.4.4 Future Outlook
8.5. SPX (SPX FLOW)
8.5.1. Company Overview
8.5.2. Financial Information
8.5.3. Portfolio of Spray Dryers
8.5.4. Future Outlook
8.6. Techni Process
8.6.1. Company Overview
8.6.2. Portfolio of Spray Dryers
8.6.3 Future Outlook
8.7. Labultima
8.7.1. Company Overview
8.7.2. Portfolio of Spray Dryers
8.7.3 Future Outlook
8.8. Other Manufacturers
8.8.1. Advanced Drying Systems
8.8.2. ProCepT
8.8.3. Raj Process Equipments
8.8.4. Spray Drying Systems (SDS)
9. CASE STUDY ON THE KEY COMPETING STRATEGY: LYOPHILIZATION
9.1. Chapter Overview
9.2. Historical Background
9.3. Underlying Principle
9.4. Equipment
9.5. Advantages and Disadvantages
9.6. Applications of Lyophilization
9.6.1. Pharmaceutical and Biotechnology Industry
9.6.2. Food Industry
9.6.3. Microbiology
9.6.4. Chemical Industry
9.6.5. Dairy Industry
9.6.6. Nutraceutical Industry
9.6.7. Floral Lyophilization
9.6.8. Other Applications
9.7. Lyophilization Process for Biopharmaceuticals
9.7.1. Formulation and Filling
9.7.2. Freezing
9.7.3. Primary Drying
9.7.4. Secondary Drying
9.8. Lyophilization Service Providers for Biopharmaceuticals
10. MERGERS AND ACQUISITIONS
10.1. Chapter Overview
10.2. Pharmaceutical Spray Drying: Mergers and Acquisitions
10.2.1. Year-wise Trend
10.2.2. Geographical Activity
10.2.3. Ownership Change Matrix
10.3. Key Acquisitions: Deal Multiples
11. MARKET SIZING AND FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology
11.3. Pharmaceutical Spray Drying Services Market, 2018-2028 (USD Billion)
11.4. Pharmaceutical Spray Drying Services Market, 2018-2028: Distribution by Product Type (Pharmaceuticals / Biologics) (USD Billion)
11.5. Pharmaceutical Spray Drying Services Market, 2018-2028: Distribution by Region (USD Billion)
11.5.1. Pharmaceutical Spray Drying Services Market: North America (USD Billion)
11.5.2. Pharmaceutical Spray Drying Services Market: Europe (USD Billion)
11.5.3. Pharmaceutical Spray Drying Services Market: Asia Pacific and Rest of the World (USD Billion)
11.6. Pharmaceutical Spray Drying Services Market, 2018-2028: Distribution by Type of Nozzle (USD Billion)
12. SWOT ANALYSIS
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Concluding Remarks
13. CONCLUSION
13.1. Given its Benefits Over Alternative Formulation Technologies, the Applications of Spray Drying Are Likely to Increase in the Pharmaceutical and Biotechnology Sector
13.2. Several Stakeholders with Spray Drying Capabilities Have Established their Presence Across Different Regions; North America and Europe have Emerged as Key Hubs
13.3. Players are Actively Procuring Spray Drying Facilities and Capabilities; This is Evident From the Number of Acquisitions that have Recently Taken Place
13.4 Advanced Technologies, such as Aseptic Spray Drying, Are Expected to Positively Impact the Future Adoption
13.5. Despite Various Challenges and Competition from Legacy Drying Technologies, the Market is Anticipated to Grow at an Annualized Rate of 17% Between 2018 and 2028
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Idifarma, Manuel Leal, Business Development Director
14.3. Sam De Costa, Stabilisation Projects Manager, Nova Laboratories
14.4. Anonymous, Founder, Mid-sized India Based Spray Dryer Manufacturer
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES
Figure 3.1 Spray Drying: A Schematic View of Equipment
Figure 3.2 Spray Drying: Key Steps Involved in the Process
Figure 3.3 Spray Drying: Advantages and Limitations
Figure 4.1 Spray Drying: Key Applications in Pharmaceutical Industry
Figure 4.2 Biopharmaceutics Classification System
Figure 4.3 Dispersion Mechanism for Inhalable Nanoparticles
Figure 5.1 Pharmaceutical Spray Dryers: Distribution by Type of Nozzles
Figure 5.2 Pharmaceutical Spray Dryers: Distribution by Inlet Temperature
Figure 5.3 Pharmaceutical Spray Dryers: Distribution by Atomizing Gas
Figure 5.4 Pharmaceutical Spray Dryers: Key Manufacturers
Figure 5.5 Pharmaceutical Spray Drying Service Providers: Distribution by Scale of Operation
Figure 5.6 Pharmaceutical Spray Drying Service Providers: Distribution by cGMP Availability
Figure 5.7 Pharmaceutical Spray Drying Service Providers: Popularly Used Spray Dryers
Figure 6.1 Pharmaceutical Spray Drying Service Providers: Competitive Landscape
Figure 6.2 Pharmaceutical Spray Dryer Manufacturers: Competitive Landscape
Figure 6.3 Pharmaceutical Spray Drying Capabilities: Geographical Landscape
Figure 8.1 Buchi: Annual Revenues, 2012- 2017 (EUR Billion)
Figure 8.2 GEA Niro: Annual Revenues, 2012- 2017 (USD Billion)
Figure 8.3 SPX: Annual Revenues, 2012- 2017 (USD Billion)
Figure 9.1 Lyophilization: Historical Timeline
Figure 9.2 Phase Diagram of Water
Figure 9.3 Sublimation of Ice Crystals
Figure 9.4 Components of a Lyophilizer
Figure 9.5 Applications of Lyophilization
Figure 9.6 Formulation and Filling of Biopharmaceuticals: Key Steps
Figure 9.7 Freezing of Biopharmaceuticals: Key Steps
Figure 10.1 Pharmaceutical Spray Drying Mergers and Acquisitions: Year-Wise Trend
Figure 10.2 Pharmaceutical Spray Drying Mergers and Acquisitions: Geographical Activity
Figure 10.3 Pharmaceutical Spray Drying Mergers and Acquisitions: Distribution by Local and International Acquisitions
Figure 10.4 Pharmaceutical Spray Drying Mergers and Acquisitions: Ownership Change Matrix
Figure 11.1 Pharmaceutical Spray Drying Services Market, 2018-2028: Base Scenario (USD Billion)
Figure 11.2 Pharmaceutical Spray Drying Services Market, 2018, 2023, 2028: Distribution by Product Type (Pharmaceuticals / Biologics), (USD Billion)
Figure 11.3 Pharmaceutical Spray Drying Services Market, 2018, 2023 and 2028: Distribution by Region
Figure 11.5 Pharmaceutical Spray Drying Services Market, 2018-2028: North America, Base Scenario (USD Billion)
Figure 11.6 Pharmaceutical Spray Drying Services Market, 2018-2028: Europe, Base Scenario (USD Billion)
Figure 11.7 Pharmaceutical Spray Drying Services Market, 2018-2028: Asia Pacific and Rest of the World, Base Scenario (USD Billion)
Figure 11.8 Pharmaceutical Spray Drying Services Market, 2018-2028: Distribution by Type of Nozzle, Base Scenario (USD Billion)
Figure 12.1 Pharmaceutical Spray Drying Market: SWOT Analysis
Figure 12.2 Pharmaceutical Spray Drying Market: Comparison of SWOT Factors, Harvey Ball Analysis
Figure 13.1 Pharmaceutical Spray Drying Services Market: 2018, 2022 and 2028 (USD Billion)
Table 3.1 Types of Atomizers Used in Spray Dryers
Table 3.2 Spray Dryers: Modes of Operation
Table 3.3 Comparison of Spray Drying and Lyophilization
Table 3.4 Comparison of Spray Drying and Spray Freeze Drying
Table 4.1 Examples of Spray Dried Drugs for Improved Solubility and Bioavailability
Table 4.2 Examples of Spray Dried Inhalation Drugs
Table 4.3 Polymers Used for Drug Encapsulation
Table 4.4 Polymers Used for Controlled and Immediate Release
Table 4.5 Examples of Spray Dried Drugs for Taste Masking
Table 5.1 Pharmaceutical Spray Drying Service Providers: Capabilities
Table 5.2 Pharmaceutical Spray Dryer Manufacturers: Competitive Landscape
Table 5.3 Pharmaceutical Spray Drying Manufacturers and Service Providers: Geographical Distribution
Table 6.1 Pharmaceutical Spray Dryers: List of Manufacturers
Table 6.2 Pharmaceutical Spray Drying: List of Service Providers
Table 6.3 Pharmaceutical Spray Drying Service Providers: Scale of Operation
Table 6.4 Pharmaceutical Spray Drying: Companies with In-house Facilities
Table 6.5 Pharmaceutical Spray Drying: Companies Involved in Bioavailability Enhancement
Table 7.1 Pharmaceutical Spray Drying Service Providers: List of Companies Profiled
Table 7.2 Company Profile: Ajinomoto (Omnichem)
Table 7.3 Company Profile: Almac Group
Table 7.4 Company Profile: Biotech Investment Group (Formex)
Table 7.5 Company Profile: Catalent Pharma Solutions
Table 7.6 Company Profile: Coriolis Pharma
Table 7.7 Company Profile: Evotec (Aptuit / Kuecept)
Table 7.8 Company Profile: Fuji Chemical Industry
Table 7.9 Company Profile: Hovione
Table 7.10 Company Profile: Idifarma
Table 7.11 Company Profile: Lonza (Capsugel / Bend Research)
Table 7.12 Company Profile: Micro-Sphere
Table 7.13 Company Profile: Nova Laboratories
Table 7.14 Company Profile: Patheon (Agere Pharmaceuticals)
Table 7.15 Company Profile: Pulse Combustion Systems
Table 7.16 Company Profile: Richman Chemical
Table 7.17 Company Profile: Siegfried
Table 7.18 Company Profile: Upperton
Table 8.1 Pharmaceutical Spray Dryer Manufacturers: List of Companies Profiled
Table 8.2 Buchi Labortechnik Spray Dryers Portfolio: Key Features
Table 8.3 Buchi Spray Dryers: Clients
Table 8.4 GEA Spray Dryers Portfolio: Key Features
Table 8.5 GEA Spay Drying Services: Clients
Table 8.6 Hemraj India Spray Dryers Portfolio: Key Features
Table 8.7 Hemraj India: Clients
Table 8.8 SPX Spray Dryers Portfolio: Key Features
Table 8.9 SPX: MicraSpray Dryer Models
Table 8.10 Labultima Portfolio: Key Features
Table 8.11 Labultima Spay Drying Services: Clients
Table 8.12 Advanced Drying Systems Spray Dryers Portfolio: Key Features
Table 8.13 SDS Spray Dryers Portfolio: Key Features
Table 9.1 Lyophilization: Advantages and Disadvantages
Table 9.2 List of Lyophilization Service Providers for Biopharmaceuticals
Table 9.3 Lyophilization Service Providers for Biopharmaceuticals: Type of Biopharmaceuticals Lyophilized
Table 9.4 Lyophilization Service Providers for Biopharmaceuticals: Scale of Operation
Table 10.1 Pharmaceutical Spray Drying: List of Mergers and Acquisitions
Table 10.2 Pharmaceutical Spray Drying: Deal Multiples of Mergers and Acquisitions
Table 15.1 Pharmaceutical Spray Dryers: Distribution by Type of Nozzles
Table 15.2 Pharmaceutical Spray Dryers: Distribution by Inlet Temperature
Table 15.3 Pharmaceutical Spray Dryers: Distribution by Atomizing Gas
Table 15.4 Pharmaceutical Spray Dryers: Key Manufacturers
Table 15.5 Pharmaceutical Spray Drying Service Providers: Distribution by Scale of Operation
Table 15.6 Pharmaceutical Spray Drying Service Providers: Distribution by cGMP Availability
Table 15.7 Pharmaceutical Spray Drying Service Providers: Popularly Used Spray Dryers
Table 15.8 Buchi: Annual Revenues, 2012-2017 (EUR Billion)
Table 15.9 GEA: Annual Revenues, 2012- 2017 (EUR Billion)
Table 15.10 SPX: Annual Revenues, 2012- 2017 (USD Billion)
Table 15.11 Pharmaceutical Spray Drying Mergers and Acquisitions: Year-Wise Trend
Table 15.12 Pharmaceutical Spray Drying Mergers and Acquisitions: Key Geographical Regions
Table 15.13 Pharmaceutical Spray Drying Services Market, 2018, 2023, 2028: Distribution by Product Type (Pharmaceuticals / Biologics), (USD Billion)
Table 15.14 Pharmaceutical Spray Drying Services Market, 2018, 2023 and 2028: Distribution by Region (USD Billion)
Table 15.15 Pharmaceutical Spray Drying Services Market, 2018-2028: North America, Conservative Scenario (USD Billion)
Table 15.16 Pharmaceutical Spray Drying Services Market, 2018-2028: North America, Base Scenario (USD Billion)
Table 15.17 Pharmaceutical Spray Drying Services Market, 2018-2028: North America, Optimistic Scenario (USD Billion)
Table 15.18 Pharmaceutical Spray Drying Services Market, 2018-2028: Europe, Conservative Scenario (USD Billion)
Table 15.19 Pharmaceutical Spray Drying Services Market, 2018-2028: Europe, Base Scenario (USD Billion)
Table 15.20 Pharmaceutical Spray Drying Services Market, 2018-2028: Europe, Optimistic Scenario (USD Billion)
Table 15.21 Pharmaceutical Spray Drying Services Market, 2018-2028: Asia Pacific and Rest of the World, Conservative Scenario (USD Billion)
Table 15.22 Pharmaceutical Spray Drying Services Market, 2018-2028: Asia Pacific and Rest of the World, Base Scenario (USD Billion)
Table 15.23 Pharmaceutical Spray Drying Services Market, 2018-2028: Asia Pacific and Rest of the World, Optimistic Scenario (USD Billion)
Table 15.24 Pharmaceutical Spray Drying Services Market, 2018-2028: Distribution by Type of Nozzle (USD Billion)
Table 15.25 Pharmaceutical Spray Drying Services Market: 2018, 2022 and 2028 (USD Billion)Figure 3.1 Spray Drying: A Schematic View of Equipment
The following companies and organizations have been mentioned in the report:Acmefil Engineering Systems
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
SUBSCRIBE TO INDUSTRY UPDATES